IFNA2 and animal viral hepatitis: Recombinant analogues of IFNα2 and IFNβ1, and more recently pegylated forms of IFNα2, have found wide application for the treatment of chronic viral hepatitis and remitting relapsing multiple sclerosis (RRMS) respectively.